Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (321-330 of 323) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 323 results.
American Heart Journal|September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trialManvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Journal of the American College of Cardiology|November 19, 2013
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjectsYoav Ben-Shlomo, Melissa Spears, Chris Boustred, et al.
Pageof 33

Showing results (321-330 of 323) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 323 results.
American Heart Journal|September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trialManvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Journal of the American College of Cardiology|November 19, 2013
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjectsYoav Ben-Shlomo, Melissa Spears, Chris Boustred, et al.
Pageof 33